SEC Filing Summary: Form 8-K
Business Context and Reporting Period
Company: AdventRX Pharmaceuticals, Inc. (Note: Request metadata listed "Savara Inc", but the filing text identifies the registrant as AdventRX Pharmaceuticals, Inc.)
Filing Date: July 5, 2005
Reporting Period: Current report for the event date of July 5, 2005.
Business Context: The company is a Delaware corporation headquartered in San Diego, California, operating in the pharmaceutical sector.
Key Financial Metrics
This filing is a Current Report (Form 8-K) regarding a corporate event and does not contain financial statements. Consequently, the filing text does not provide clear values for revenue, profit, cash flow, margins, debt, or liquidity.
Material Changes
The material change reported is the inclusion of the Company's common stock in the Russell Investment Group's new Russell Microcap Index, effective as of the report date.
Guidance, Outlook, and Risks
Management Commentary: The filing references a press release (Exhibit 99.1) regarding the index inclusion but does not provide specific management commentary, forward-looking guidance, or risk factors within the body of this 8-K text.
Unusual Items: None reported beyond the index inclusion.
Key Facts for Investor Verification
- Verify the effective date of inclusion in the Russell Microcap Index.
- Review the attached press release (Exhibit 99.1) for details on the impact of index inclusion on trading volume or liquidity.
- Confirm the company's current ticker symbol and trading status on the relevant exchange.
- Note the discrepancy between the request metadata ("Savara Inc") and the filing registrant ("AdventRX Pharmaceuticals, Inc").